About 100 reports

LONZA: OPPORTUNITY ASSESSMENT Opportunity Assessment Merck delivers novel health solutions through its prescription medicines, biologic therapies, and consumer care products.

  • Biological Therapy
  • World
  • Forecast
  • Merck & Co., Inc.
  • Sanofi S.A.

Glybera approved in Germany in 2015 for the treatment of rare blood condition with gene therapy costs about atleast $## million per treatment.

  • Biological Therapy
  • World
  • Market Size
  • Eppendorf AG
  • GE Healthcare Limited
  • 6 Global Cancer Biological Therapy Market, By Type
  • MARKET DYNAMICS FOR GLOBAL CANCER BIOLOGICAL THERAPY MARKET

Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. There are many biological therapies that have been approved and being used by various cancer...

  • Biological Therapy
  • World
  • Forecast
  • Market Size
  • Pfizer Inc.

Hence to the patient. to manufacture one dose of autologous therapy would cost USD ##-##.

  • Biological Therapy
  • Biopharmaceutical
  • Biotechnology
  • Vaccine
  • World

The application of biosimilars in blood disease treatment is one of the highest revenue generating segment owing to the high-priced reference biologics and frequent application.

  • Biological Therapy
  • Biopharmaceutical
  • Biosimilar
  • Pharmaceutical
  • World

The multi-modality treatment of cancer may include surgery, chemotherapy, biological therapy, or radiation therapy.

  • Biological Therapy
  • World
  • Carl Zeiss Meditec AG
  • Eckert & Ziegler AG
  • Varian Medical Systems, Inc.

Biologics: Targets and Therapy; ##(##): ##-##.

  • Biological Therapy
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • World

Chemotherapy may be used alone or with RT or a biological therapy.

  • Biological Therapy
  • Leukemia
  • Monoclonal Antibody
  • Therapy
  • World

EXPERT OPINION ON BIOLOGICAL THERAPY; ##(##): ##-##.

  • Biological Therapy
  • Epidemiology
  • Therapy
  • Transplantation
  • World

In Europe, the EC is one of the governmental organization that funds for biologicals research and development.

  • Biological Therapy
  • Cell Therapy
  • Therapy
  • Tissue Engineering
  • World

CHIMERIC ANTIGEN RECEPTOR-T CELL THERAPY CAR-T CELL THERAPIES FORM ONE OF THE MAJOR ARMS OF THE EXPERIMENTAL BIOLOGICAL ANTI-CANCER THERAPIES IN THE PHARMACEUTICAL MARKET.

  • Automotive
  • Biological Therapy
  • Motor Vehicle
  • Therapy
  • World

IT CURRENTLY OPERATES AS ONE OF THE WHOLLY OWNED SUBSIDIARIES OF COBRA BIOLOGICS HOLDING.

  • Biological Therapy
  • DNA
  • Gene Therapy
  • Viral Vector
  • World

SAMSUNG BIOLOGICS' PLANT ### CAME INTO OPERATION IN MAY 2011.

  • Biological Therapy
  • Biopharmaceutical
  • Cell Therapy
  • Manufacturing
  • World

Leucotropin is a highly purified preparation of a monomeric, biologically active molecule.

  • Biological Therapy
  • Clinical Trial
  • Hospital
  • Lymphoma
  • World

It is comprised of the delivery of a therapeutic gene, protein Phosphatase-## Inhibitor-## (I- ##) with the use of Biological NanoParticles (BNPs) and the Self-Complementary Vector Technology.

  • Biological Therapy
  • World
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc
  • Global Cytokine Market in USD million, by Therapeutic Application, 2014 to 2022

There is an increase in access and acceptance of the cytokines immunotherapy, a type of biological therapy to treat cancer.

  • Biological Therapy
  • Cytokine
  • United States
  • World
  • Market Size

" Based on those results, we will determine whether we will investigate this biologic therapy in a longer study, or perhaps consider studying a combination therapy that involves more than one biologic therapy. "

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • World

SMC restriction: for use in patients in whom other non-biologic systemic treatments (methotrexate, ciclosporin and acitretin) are not appropriate or have failed and who are considered unsuitable for biologic therapy given their current disease state or personal pr

  • Autoimmune Disease
  • Biological Therapy
  • Clinical Trial
  • Dermatological Condition
  • World

The CBER regulates biologics including allergenic extracts blood and blood components, gene therapy products, devices and test kits human tissue and cellular products used in transplantation and vaccines.

  • Biological Therapy
  • Cell Therapy
  • World
  • Market Size
  • Selexis SA

The company' s product portfolio includes biologics, prescription pharmaceuticals and vaccines.

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • United States
  • World

After ## week without therapy, combined therapy is resumed at the beginning of week ##.

  • Biological Therapy
  • Breast Cancer
  • Therapy
  • Transplantation
  • World
  • PIPELINE BY SYNTRIX BIOSYSTEMS INC, H1 2018

After ## week without therapy, combined therapy is resumed at the beginning of week ##.

  • Biological Therapy
  • Breast Cancer
  • Therapy
  • Transplantation
  • World

These systemic drugs offer good efficacy, however, as biologics they can cause serious side effects.

  • Autoimmune Disease
  • Biological Therapy
  • Clinical Trial
  • Pharmaceutical
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Progenics Pharmaceuticals Inc ## ## ## ## ## ## ## ## United Therapeutics Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## APEIRON Biologics AG ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Y-mAbs Therapeutic

  • Biological Therapy
  • Clinical Trial
  • Oncology
  • Therapy
  • World

FDA to obtain " fast track" designation for CVBT-##B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-## (FGF-##).

  • Biological Therapy
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • World

After ## week without therapy, combined therapy is resumed at the beginning of week ##.

  • Biological Therapy
  • Breast Cancer
  • Therapy
  • World
  • Product Initiative

One patient showed imaging evidence suggestive of antitumor biological activity.

  • Biological Therapy
  • Breast Cancer
  • Colony-Stimulating Factor
  • Therapy
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## Coherus BioSciences Inc ## ## ## ## ## Pfizer Inc ## ## ## ## ## PTC Therapeutics Inc ## ## ## ## ## Amgen Inc ## ## ## ## ## AbbVie Inc ## ## ## ## ## Novartis AG ## ## ## ## ## medac GmbH ## ## ## ## ## C.

  • Biological Therapy
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Therapy
  • World

Using a Bayesian statistical analysis, there was high posterior probability (##%) that the ACR## RR of bimekizumab at Week ## was greater than those reported for current standard of care biologic treatments, including anti-IL-##A therapies.

  • Biological Therapy
  • Cytokine
  • Interleukin
  • Therapy
  • World

Highlights for Taltz at EULAR include three-year safety and efficacy data from SPIRIT-P##, a Phase ## study evaluating Taltz for the treatment of psoriatic arthritis in patients naïve to biologic treatment.

  • Autoimmune Disease
  • Biological Therapy
  • Clinical Trial
  • World
  • Product Initiative